English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Apr 24, 2023

Tempus Announces Seven Abstracts Accepted For Presentation at the American Association for Cancer Research Annual Meeting 2023

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community

Patient Daily | Apr 24, 2023

Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023

Patient Daily | Apr 24, 2023

Axtria And HealthVerity Announce Strategic Partnership To Enable Next-Gen Real-World Data, Analytics, And Campaign Optimization Solutions For Life Sciences Organizations

Patient Daily | Apr 24, 2023

Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting

Trending

Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'

+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'

+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment

Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’

  • « First
  • «
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily